Is it safe to give Bromphed (phenylephrine and bromhexine) to a 5-year-old child for cough?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Do Not Give Bromphed to a 5-Year-Old for Cough

I strongly recommend against using Bromphed (or any over-the-counter cough and cold medication) in a 5-year-old child for cough. These medications have minimal to no proven benefit and carry significant safety risks, including potential for serious adverse events and death from toxicity in young children.

Why This Recommendation

Guideline Evidence is Clear

The 2020 CHEST guidelines explicitly state that over-the-counter cough and cold medicines should not be prescribed for children until they have been shown to make cough less severe or resolve sooner 1. The evidence shows these medications provide little, if any, benefit for symptomatic control of cough in children, while preparations containing antihistamines (like the brompheniramine in Bromphed) are specifically associated with adverse events 1.

Safety Concerns Are Substantial

  • The FDA issued warnings against using OTC cough and cold medications in young children, leading manufacturers to voluntarily relabel products as "do not use in children under 4 years of age" 1
  • While your child is 5 years old (technically above this cutoff), the safety margin remains narrow
  • Reported deaths from toxicity have occurred in young children using these products 1
  • The antihistamine component (brompheniramine) has minimal efficacy for relieving cough in children, contrary to adult data 1

FDA Drug Label Restrictions

The Bromphed drug label specifically states: "Safety and effectiveness in pediatric patients below the age of 6 months have not been established" 2. While it doesn't explicitly prohibit use at age 5, the label warns about "higher risk of intolerance of antihistamines in small infants generally" and requires caution due to the antihistamine component 2.

What to Do Instead

First-Line Recommendation: Honey

For children over 1 year of age, honey offers more relief for cough symptoms than no treatment, diphenhydramine, or placebo 1. This is the only symptomatic treatment with evidence-based support in pediatric cough.

  • Give 1-2 teaspoons as needed
  • Do not use in children under 12 months (botulism risk)

Treat Based on Etiology, Not Symptoms

The guidelines emphasize that cough in children should be treated based on the underlying cause, not symptomatically 1. Consider:

  • Viral upper respiratory infection: Most common cause; self-limited; supportive care only
  • Asthma: May require inhaled corticosteroids if cough is asthma-related
  • Bacterial infection: Antibiotics if indicated
  • Environmental triggers: Address smoke exposure, allergens

When to Seek Further Evaluation

All children with chronic cough (lasting >4 weeks) should have thorough clinical review to identify:

  • Pointers to underlying respiratory disease (wheezing, exercise intolerance, recurrent pneumonia)
  • Systemic illness indicators (fever, weight loss, failure to thrive)
  • Red flags requiring immediate attention (respiratory distress, hemoptysis)

Critical Pitfalls to Avoid

  1. Do not use codeine-containing medications - potential for serious side effects including respiratory distress 1
  2. Avoid combination products - increased risk of accidental overdose and adverse events 3
  3. Therapeutic errors are common - many cases of toxicity result from dosing mistakes 4
  4. Diphenhydramine specifically is associated with high frequency of severe adverse effects 4

The Bottom Line

The bromhexine component in Bromphed has been studied and found to be inactive in modifying cough in multiple studies of patients with chronic bronchitis or bronchiectasis 5. Combined with an antihistamine that doesn't work for pediatric cough and a decongestant (phenylephrine) recently deemed ineffective by the FDA 6, this medication offers no proven benefit while carrying real risks.

Use honey for symptomatic relief and focus on identifying and treating the underlying cause of the cough 1.

Related Questions

Is Hylands Mucus & Cold Relief (diphenhydramine and phenylephrine) an appropriate alternative for a 2‑ to 5‑year‑old child?
Is it safe to give an 8-year-old with a cough both Bromfed DM (brompheniramine/pseudoephedrine/dextromethorphan) and Benadryl (diphenhydramine), and what are the appropriate doses?
Is it safe to give Bromfed (brompheniramine and phenylephrine) to a 9-year-old child for cough?
In a 1-year-old infant with persistent cough and flu symptoms despite paracetamol and vitamin therapy, what are the appropriate supportive measures, safe dosing of paracetamol and ambroxol, and is a cough-and-cold (CTM) preparation recommended?
Can a 15‑month‑old child with cough and cold be given a syrup containing sodium citrate, guaifenesin, dextromethorphan, and phenylpropanolamine?
Based on the BAARS‑IV scores (current ADHD total score 36, borderline‑to‑mild; childhood combined score 47, moderate‑to‑severe) and reported functional impairment in school, home, work, and social settings, does this adult meet criteria for Attention‑Deficit/Hyperactivity Disorder, combined type, and what pharmacologic and non‑pharmacologic treatment should be initiated?
What is bilastine (second‑generation H1‑receptor antagonist)?
Can a patient allergic to gabapentin safely take Lyrica (pregabalin)?
Is bedtime clonidine indicated for a patient taking Adderall XR (mixed amphetamine salts) 10 mg daily, experiencing anxiety and irritability with any afternoon stimulant dose, who is also on escitalopram 20 mg daily and magnesium glycinate 200 mg at bedtime, to improve sleep and ADHD symptoms?
What are the possible causes of intermittent neuropathy?
What assessment findings should be evaluated in an adult with a left middle cranial fossa extra‑axial lesion?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.